Skip to main content
Caplight Logo









QuantifiCare

QuantifiCare

Private
BiotHealthcare & Life Scienceshttps://www.quantificare.com/

Last Round

Grant

Oct 23, 2024

Est. Valuation

$27.5M

Total Funding Raised

$5.5M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

QuantifiCare is a medical technology company that provides 2D and 3D imaging systems and clinical trial services for aesthetic and dermatological applications.

Sector

Healthcare & Life Sciences

Verticals

Medical Imaging, Clinical Trials, Medical Devices, Computer Vision

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting, Subscription SaaS

AI Layer

Application

Keywords

3D imagingclinical trial imagingimaging CROdermatology imagingaesthetic medicineskin analysismedical devicecomputer visionclinical researchcontract research organizationCROdigital healthmedtechclinical endpointsimage analysis

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

QuantifiCare Comparables

Compare QuantifiCare with similar companies based on industry and business-model similarity.

QuantifiCare comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Canfield Scientific
91%
Miravex Limited
84%
BID Equity
81%

QuantifiCare Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantOct 23, 2024
Series ASep 3, 2019

Key People

Founding team and executive leadership

Johann Montay

Group Chief Financial Officer

Executive Team

Pascale Buisson

CFO

Executive Team

Stephane Boyeau

Chief Information Officer, Chief Operating Officer

Executive Team

QuantifiCare Investors

Notable investors and investment history

QuantifiCare investors
InvestorRounds
LBO FranceSeries A
BpifranceGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 24, 2026

    Monthly visitors grew 316% MoM, reaching 12.8K.

  • Oct 30, 2024

    Monthly visitors increased 47% MoM, reaching 6.3K.

QuantifiCare Filings

Explore SEC and related filing metadata, where available.

QuantifiCare filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about QuantifiCare's valuation, stock price, and market status.

Is QuantifiCare a public or private company?

QuantifiCare is a private company.

What is the current stock price of QuantifiCare?

QuantifiCare is a private company with no public stock price. No recent secondary market data is available.

How much is QuantifiCare worth (valuation)?

QuantifiCare's valuation is estimated at $27.5M based on funding round data.

Can I buy QuantifiCare stock?

QuantifiCare shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was QuantifiCare's last funding round?

QuantifiCare's most recent funding round was Grant on September 3, 2019.

Who are the main investors in QuantifiCare?

Key investors in QuantifiCare include LBO France.

Will QuantifiCare IPO soon?

No public IPO plans have been announced for QuantifiCare.

How can I track QuantifiCare secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor QuantifiCare's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBiot
Employee Range72
Year Founded2001
Last FundingOct 23, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?